At a glance
The May 17, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on antigen testing, biosafety, SARS-CoV-2 variants, and laboratory supplies, as well as updates from FDA.
Agenda
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
Antigen Testing Guidance: Muktha Natrajan, CDC Division of Laboratory Systems (DLS)
Biosafety Guidance Update: Aufra C. Araujo, CDC Division of Laboratory Systems (DLS)
SARS-CoV-2 Variants Update: Steve Oberste, CDC Laboratory and Testing Task Force for the COVID-19 Response
How the Federal Government is Addressing Laboratory Supply Issues: Steven Santos, HHS Testing and Diagnostics Workgroup, and Matthew Hubbard, HHS Testing and Diagnostics Workgroup
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)